ATE155790T1 - Synthetische lipid-a clykoconjugate-antigene und deren verwendung in impfstoffen - Google Patents

Synthetische lipid-a clykoconjugate-antigene und deren verwendung in impfstoffen

Info

Publication number
ATE155790T1
ATE155790T1 AT93104369T AT93104369T ATE155790T1 AT E155790 T1 ATE155790 T1 AT E155790T1 AT 93104369 T AT93104369 T AT 93104369T AT 93104369 T AT93104369 T AT 93104369T AT E155790 T1 ATE155790 T1 AT E155790T1
Authority
AT
Austria
Prior art keywords
vaccines
antigens
clycoconjugate
synthetic lipid
synthetic
Prior art date
Application number
AT93104369T
Other languages
English (en)
Inventor
Massimo Porro
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE155790T1 publication Critical patent/ATE155790T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT93104369T 1992-05-07 1993-03-17 Synthetische lipid-a clykoconjugate-antigene und deren verwendung in impfstoffen ATE155790T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87940392A 1992-05-07 1992-05-07

Publications (1)

Publication Number Publication Date
ATE155790T1 true ATE155790T1 (de) 1997-08-15

Family

ID=25374087

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93104369T ATE155790T1 (de) 1992-05-07 1993-03-17 Synthetische lipid-a clykoconjugate-antigene und deren verwendung in impfstoffen

Country Status (14)

Country Link
EP (1) EP0570682B1 (de)
JP (1) JPH0641200A (de)
KR (1) KR930023369A (de)
AT (1) ATE155790T1 (de)
AU (1) AU664609B2 (de)
CA (1) CA2095588A1 (de)
DE (1) DE69312391T2 (de)
DK (1) DK0570682T3 (de)
ES (1) ES2104984T3 (de)
FI (1) FI932053L (de)
GR (1) GR3024706T3 (de)
IL (1) IL105605A0 (de)
NO (1) NO180234C (de)
SG (1) SG47582A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008214256A (ja) * 2007-03-02 2008-09-18 Yaizu Suisankagaku Industry Co Ltd 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤
EP2326671A4 (de) * 2008-09-05 2012-10-03 Ca Nat Research Council Auf lps basierende impfstoffe
JP2019513137A (ja) * 2016-03-30 2019-05-23 アユヴィス リサーチ インク.Ayuvis Research, Inc. 新規組成物及び治療方法
CN110174363A (zh) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
JPH04507244A (ja) * 1989-07-27 1992-12-17 ユニバックス・バイオロジクス・インコーポレイテッド リピドa類似体/免疫原性担体コンジュゲートおよびそのワクチンとしての使用

Also Published As

Publication number Publication date
EP0570682B1 (de) 1997-07-23
FI932053A7 (fi) 1993-11-08
EP0570682A1 (de) 1993-11-24
JPH0641200A (ja) 1994-02-15
ES2104984T3 (es) 1997-10-16
GR3024706T3 (en) 1997-12-31
NO180234C (no) 1997-03-12
CA2095588A1 (en) 1993-11-08
SG47582A1 (en) 1998-04-17
IL105605A0 (en) 1993-09-22
DE69312391T2 (de) 1997-12-11
NO180234B (no) 1996-12-02
NO931655L (no) 1993-11-08
FI932053L (fi) 1993-11-08
FI932053A0 (fi) 1993-05-06
AU3841993A (en) 1993-11-11
DE69312391D1 (de) 1997-08-28
DK0570682T3 (da) 1998-02-16
NO931655D0 (no) 1993-05-06
KR930023369A (ko) 1993-12-18
AU664609B2 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
ATE184274T1 (de) N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
NO910832L (no) Formlegemer.
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
HU9401511D0 (en) Vaccine against streptococcus suls infection
BG94868A (bg) Мутант на бактерията сlоsтrifiuм нisтоlyтiсuм, метод за получаването му и използуването му за производство на свободна от клострипаин колагеназа
ATE155790T1 (de) Synthetische lipid-a clykoconjugate-antigene und deren verwendung in impfstoffen
DE3777486D1 (de) Hydroperoxydierte poly-n-vinyllactam-teilchen, verfahren und verwendung davon.
GR81181B (en) Substituted o-acyl-glycosylamide, method for the preparation thereof
DE69010545D1 (de) Extraktionsverfahren.
AU6873587A (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
FI922125A7 (fi) Mikrobiologinen menetelmä 5-hydroksipyratsiinikarboksyylihapon valmistamiseksi
DE69111401D1 (de) Tert-Butyloxycarbonyl-L-Tyrosyl-Peptidoglycanmonomer und deren 125 I-markiertes Derivat, deren Herstellung und Verwendung.
FI911126A0 (fi) Organokupraattimenetelmä kefprotsilin valmistamiseksi
FI821141L (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
FR2659651B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphenylene diamines.
IT1240742B (it) Stabilizzanti per polimeri a basso grado di polverosita'
GB2231079B (en) A support rail
IT8653055V0 (it) Sistema di schiusura per vetrate pieghevoli senza l ausilio di meccanismi di chiusura tradizionali
IT9021155A0 (it) "procedimento di desolforazione microbiologica del carbone"
IT1221326B (it) Impianto perfezionato per la formatura di lastre in vetrocamera
IT1228141B (it) Metodo per la produzione concimi composti umificanti bilanciati di pollina e l'eliminazione degli odori per combustione con il recupero del calore
BR6900355U (pt) Embalagem para meios de cultura bacteriologica